# Study of Lanadelumab in Healthy Japanese and Matched Caucasian Adult Subjects

> **NCT03401671** · PHASE1 · COMPLETED · sponsor: **Shire** · enrollment: 32 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Lanadelumab

## Key facts

- **NCT ID:** NCT03401671
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-15
- **Primary completion:** 2018-05-30
- **Final completion:** 2018-05-30
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2021-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03401671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03401671, "Study of Lanadelumab in Healthy Japanese and Matched Caucasian Adult Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03401671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*